Becton Dickinson (BDX) Tops Q1 EPS by 30c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
BD Reports First Quarter Fiscal 2023 Financial Results
February 2, 2023 6:30 AM ESTExecution of BD 2025 Strategy Delivering Consistent and Durable Performance
Revenue of $4.6 billion decreased 2.8% as reported and increased 1.7% on a currency-neutral basisRevenue from base business (which excludes COVID-only diagnostic testing) grew 0.4% as reported, 5.2% currency-neutralGAAP and adjusted diluted EPS from continuing operations of $1.70 and $2.98, respectivelyCompany raises full-year revenue and adjusted EPS guidanceFRANKLIN LAKES, N.J., Feb. 2, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its first quarter of fiscal 2023, which ended December 31, 2022.
... More